Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche span> par promoteur : Institut de Recherche Pierre Fabre
Femme et Homme Max 99 ans
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
MAJ Il y a 5 ans
Efficacy of topic RV3131A-HC3221 in the prevention of polymorphic light eruption
The evaluation of the efficacy of the sunscreen RV 3131 A HC 3221 on the prevention of Polymorphic Light Eruption among subjects having PMLE history and for whom the diagnosis will be confirmed by a p...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
MAJ Il y a 5 ans
Assessment of the activity of a new cream containing betamethasone dipropionate at 0.010%, 0.025% and 0.050% versus reference products using a vasoconstriction assay in healthy subjects
This study is a pharmacodynamic study based on the corticosteroid induced skin vasoconstriction in healthy human skin. The main objective is to determine the place of new betamethasone dipropionate cr...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
MAJ Il y a 5 ans
EFFICACY AND SAFETY OF 8% CLOBETASOL NAIL LACQUER FORMULATION VERSUS VEHICLE IN NAIL PSORIASIS
Main objective : To assess the efficacy of a 6-month daily application of 8% clobetasol nail lacquer versus vehicle in fingernail psoriasis using: · The dynamic Physician (blinded expert) Global Asse...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Pierre Fabre Research Institute (Institut de Recherche Pierre Fabre) (France)
MAJ Il y a 5 ans
Efficacy and safety of two Chondroitin Sulfate preparations in patients with symptomatic osteoarthritis of the knee
Not provided at time of registration
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Homme Max 99 ans
Institut de Recherche Pierre Fabre
MAJ Il y a 5 ans
Exploratory study of besipirdine efficacy and safety in male patients with persistent stress urinary incontinence after radical prostatectomy
To assess the clinical efficacy of besipirdine (20 mg b.i.d.) compared to placebo in male patients with persistent stress urinary incontinence further to radical prostatectomy
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
PIERRE FABRE MEDICAMENT (Represented by: Institut de Recherche Pierre Fabre)
MAJ Il y a 5 ans
A 4-week double-blind placebo-controlled pilot study, evaluating niacin-induced flushing and lipid parameter effects of V0002 CA 1g 3 capsules/day associated with Niaspan® (from 375 mg to 1000 mg) in addition to usual care statin, in patients suffering from dyslipidemia with uncontrolled elevated triglycerides
To assess efficacy of V0002 CA 1 g at 3 capsules /day on preventing niacin-induced flushing promoted by Niaspan® administration
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Institut de Recherche Pierre Fabre
MAJ Il y a 5 ans
Evaluation of the impact of the moisturizing milk RV2478B on the use of corticoids and on quality of life, in a population of children with atopic dermatitis
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
MAJ Il y a 5 ans
Efficacy and safety of 0,1%, 0,5% and 1% TAZAROTENE nail lacquer formulation versus vehicle in nail psoriasis. International, multicenter, double-blind, randomized study of four parallel groups
To assess the efficacy of a 6-month daily application of 0.1% , 0.5% and 1% tazarotene fingernail lacquer in fingernail psoriasis, using Expert Physician Global Assessment (EPGA) corresponding to a bl...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
MAJ Il y a 5 ans
Study in infants with infantile hemangioma to compare propranolol gel to placebo. Estudio en lactantes con hemangioma infantil para comparar propranolol gel con placebo
To assess propranolol gel efficacy in terms of complete/nearly complete resolution of the Infantile Hemangioma at W12 compared to baseline. Analizar la eficacia de propranolol gel, expresada com...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
MAJ Il y a 5 ans
NON-INFERIORITY STUDY OF A METRONIDAZOLE 0.75% CREAM VERSUS REFERENCE THERAPY IN THE LOCAL TREATMENT OF PAPULOPUSTULAR ROSACEA
To assess the non-inferiority of a metronidazole 0.75% cream (Rosiced) in comparison to reference therapy (Rozex) in the local treatment of papulopustular rosacea
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
1
2
Suivant